‘First In-Heart Microcomputer,’ EVAR Suture-Delivery Catheter Named Top CRT Innovations

Join our community to access additional content!

CRT Community

$0.00

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Join Now!
Already have an account? Login Now

CRT Community Premium

$650 Annually

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Complimentary subscription to electronic version of the CRM Journal

Access to CRT Meeting Registration Discounts

CRT Premium Content, including on-demand videos and presentation downloads

Join Now!
Already have an account? Login Now
News

‘First In-Heart Microcomputer,’ EVAR Suture-Delivery Catheter Named Top CRT Innovations

Posted: 04/17/2021
Author:
Jason Wermers, CRTonline.org
News

The “world’s first in-heart microcomputer” and an endovascular aortic repair (EVAR) suture-delivery catheter were recognized Saturday as the best innovations of CRT 2021 Virtual.
1-3 of 4059 results
1 2 3 4 5 Next »

‘Optimal’ TR Reduction Associated With Better Functional, Clinical Outcomes After T-TEER: Registry Data

Nov 06, 2024 by
Nathan Gray, CRTonline.org

An ‘optimal’ procedural result of grade of 0/1+ regurgitation after tricuspid edge-to-edge repair (T-TEER) is associated with improved outcomes and functional status, according to an analysis of real-world patient data from the Spanish TRI-SPA registry.

Coronary Sinus Reducer Improves QoL, Symptom Severity in Patients with Refractory Angina: REDUCER-I Trial

Nov 06, 2024 by
Will Chu, CRTonline.org

A new study outlines the substantial improvements in quality of life, symptom severity and exercise capacity among patients implanted with the Coronary Sinus (CS) Reducer in treating patients with refractory angina.

CS Reducer Improves Angina Symptoms, QoL in CMD Patients: NeoVasc/Shockwave Medical-Supported Trial

Nov 06, 2024 by
Will Chu, CRTonline.org

Newly published findings reveal that the coronary sinus (CS) reducer significantly reduces angina symptoms and improves quality of life for patients with coronary microvascular dysfunction (CMD).

1-3 of 4059 results
1 2 3 4 5 Next »

Most Viewed Pages

OPTION - Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation (OPTION)

Study Identifies Similar One Year Outcomes for Two Transcatheter Heart Valves

Encouraging IVL Outcomes in ISR: NCDR Analysis

CeleCor Presents Clinical Trial Results of Zalunfiban (RUC-4), a Novel Platelet GPIIb/IIIa Inhibitor, in STEMI Patients

SCAI Expert Consensus Statement on the Management of Patients with STEMI Referred for Primary PCI

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Join our community to access additional content!

CRT Community

CRT Community Premium

News

‘First In-Heart Microcomputer,’ EVAR Suture-Delivery Catheter Named Top CRT Innovations

‘Optimal’ TR Reduction Associated With Better Functional, Clinical Outcomes After T-TEER: Registry Data

Coronary Sinus Reducer Improves QoL, Symptom Severity in Patients with Refractory Angina: REDUCER-I Trial

CS Reducer Improves Angina Symptoms, QoL in CMD Patients: NeoVasc/Shockwave Medical-Supported Trial

Most Viewed Pages

Explore the Site

Stay Connected